0%
AIR EXPOSURE
From production to injection.
100%
NANO ENCAPSULATED
Each peptide protected individually.
MAXIMUM STABILITY
Engineered to resist heat, light & time.
NO REFRIGERATION
Stable at room temperature.
PHARMACEUTICAL GRADE
Developed & manufactured in England.

THE WYNNLABS TECHNOLOGY PLATFORM

NANOCORE™
NANOCORE™
ENCAPSULATION

Individual nano-shielding of each peptide prevents interaction and degradation, ensuring maximum bioavailability.

OXYDEPLETE™
OXYDEPLETE™
TECHNOLOGY

Oxygen-free environment virtually eliminates oxidative degradation, preserving peptide purity and potency.

STABILITYMATRIX™
STABILITYMATRIX™
ENGINEERING

Advanced formulation matrix designed to maintain peptide structure, clarity, and activity over time.

AIRLOCK™
AIRLOCK™
ARCHITECTURE

Zero air exposure from manufacturing to injection through our sealed, airless cartridge system.

DUALPHASE™
DUALPHASE™
CARRIER SYSTEM

Proprietary dual-phase delivery system for optimal peptide solubility, stability and absorption.

— PROPRIETARY. PATENTED TECHNOLOGIES. UNMATCHED RESULTS. —

RETATRUTIDE
TRIPLE RECEPTOR AGONIST
GLP-1 · GIP · GLUCAGON
12MG
  • Significant weight loss
  • Improved metabolic health
  • Enhanced energy
  • Improved body composition
RETATRUTIDE
GLOW
COMING SOON
NANO ENCAPSULATED PEPTIDE BLEND
BPC-157 5mg · TB-500 10mg · GHK-Cu 50mg
TOTAL: 65MG
  • Faster injury recovery
  • Tissue repair & regeneration
  • Joint & soft tissue support
GLOW
🇬🇧
ENGINEERED
IN ENGLAND
RIGOROUS TESTING
& QUALITY CONTROL
PHARMACEUTICAL
STANDARDS ASSURED
STABLE AT ROOM
TEMPERATURE
TRUSTED BY CLIENTS
WORLDWIDE